A Study of CLN-978 in Patients With Relapsed or Refractory (R/R) B Cell Non-Hodgkin Lymphoma (B-NHL)
Conditions: NHL; NHL, Relapsed, Adult Intervention: Drug: CLN-978 Sponsor: Cullinan Oncology, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials